Japan-headquartered Fujifilm Corporation has announced the transfer of the electronic medical record (EMR) and medical-receipt systems related business of its consolidated subsidiary, Fujifilm Healthcare Systems Corporation, to Wemex Corporation, a subsidiary of PHC Holdings Corporation. The transfer is scheduled for October 2023.

Under its medium-term management plan “VISION2023,” Fujifilm is accelerating business growth in healthcare, identifying it as one of its key business fields. Fujifilm has positioned its Medical systems business as a growth driver in healthcare, and is leveraging its proprietary image processing technology and artificial intelligence (AI) technology to deploy business in a wide range of areas, including X-ray diagnostic imaging, endoscopy, ultrasound diagnostics, in-vitro diagnostics and medical IT solutions.

With medical IT solutions at the core of its business, Fujifilm is delivering high-quality diagnostic solutions globally by linking its various product lines based on the SYNAPSE medical imaging information system, which boasts the world’s top market share. 

The latest move comes after Fujifilm has decided that, amidst the effort to optimise medical systems category’s business portfolio, it would be best that the business of Fujifilm Healthcare Systems will be developed and grown by PHC, which has a strong market presence in the electronic medical record and medical-receipt systems for clinics in Japan and can expect synergies in sales and customer support.